Cargando…
Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis
Deregulated immune response and raised inflammation are the cardinal laboratory features in COVID-19 infection reflecting severity of condition. Detection of the markers will help in early diagnosis with timely therapeutic implementation and effective outcome. Observational studies have suggested al...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140259/ https://www.ncbi.nlm.nih.gov/pubmed/34041137 http://dx.doi.org/10.4103/jfmpc.jfmpc_2196_20 |
_version_ | 1783696156268691456 |
---|---|
author | Panda, Suchismita Nanda, Rachita Tripathy, Prasanta Kumar Mangaraj, Manaswini |
author_facet | Panda, Suchismita Nanda, Rachita Tripathy, Prasanta Kumar Mangaraj, Manaswini |
author_sort | Panda, Suchismita |
collection | PubMed |
description | Deregulated immune response and raised inflammation are the cardinal laboratory features in COVID-19 infection reflecting severity of condition. Detection of the markers will help in early diagnosis with timely therapeutic implementation and effective outcome. Observational studies have suggested alteration in these parameters with severity of the condition. This systematic review and meta-analysis was conducted to assess the relevance of the fact. Observational studies from databases were scrutinised and 3669 articles were identified. Further screening, based on the inclusion criteria a total of 19 articles with 3115 participants, were reviewed for meta-analysis using random effects model. Any data in median and interquartile range were converted to mean ± SD. There was a significant rise in total leukocyte count, C-reactive protein, ferritin, IL-6, IL-10, procalcitonin in severe cases but absolute lymphocyte count, CD4+ and CD8+ registered a fall in severe cases in comparison to non-severe group. Immune and inflammatory markers are significantly altered and related to severity of manifestation in COVID-19 infection. |
format | Online Article Text |
id | pubmed-8140259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-81402592021-05-25 Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis Panda, Suchismita Nanda, Rachita Tripathy, Prasanta Kumar Mangaraj, Manaswini J Family Med Prim Care Review Article Deregulated immune response and raised inflammation are the cardinal laboratory features in COVID-19 infection reflecting severity of condition. Detection of the markers will help in early diagnosis with timely therapeutic implementation and effective outcome. Observational studies have suggested alteration in these parameters with severity of the condition. This systematic review and meta-analysis was conducted to assess the relevance of the fact. Observational studies from databases were scrutinised and 3669 articles were identified. Further screening, based on the inclusion criteria a total of 19 articles with 3115 participants, were reviewed for meta-analysis using random effects model. Any data in median and interquartile range were converted to mean ± SD. There was a significant rise in total leukocyte count, C-reactive protein, ferritin, IL-6, IL-10, procalcitonin in severe cases but absolute lymphocyte count, CD4+ and CD8+ registered a fall in severe cases in comparison to non-severe group. Immune and inflammatory markers are significantly altered and related to severity of manifestation in COVID-19 infection. Wolters Kluwer - Medknow 2021-03 2021-04-08 /pmc/articles/PMC8140259/ /pubmed/34041137 http://dx.doi.org/10.4103/jfmpc.jfmpc_2196_20 Text en Copyright: © 2021 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Article Panda, Suchismita Nanda, Rachita Tripathy, Prasanta Kumar Mangaraj, Manaswini Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis |
title | Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis |
title_full | Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis |
title_fullStr | Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis |
title_full_unstemmed | Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis |
title_short | Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis |
title_sort | immuno-inflammatory predictors of disease severity in covid-19: a systematic review and meta-analysis |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140259/ https://www.ncbi.nlm.nih.gov/pubmed/34041137 http://dx.doi.org/10.4103/jfmpc.jfmpc_2196_20 |
work_keys_str_mv | AT pandasuchismita immunoinflammatorypredictorsofdiseaseseverityincovid19asystematicreviewandmetaanalysis AT nandarachita immunoinflammatorypredictorsofdiseaseseverityincovid19asystematicreviewandmetaanalysis AT tripathyprasantakumar immunoinflammatorypredictorsofdiseaseseverityincovid19asystematicreviewandmetaanalysis AT mangarajmanaswini immunoinflammatorypredictorsofdiseaseseverityincovid19asystematicreviewandmetaanalysis |